Systemic mastocytosis (SM) associated with chronic eosinophilic leukemia (SM-CEL): detection of FIP1L1/PDGFRalpha, classification by WHO criteria, and response to therapy with imatinib.

Stefan Florian, Harald Esterbauer, Thomas Binder, Leonhard Müllauer, Oskar A Haas, Wolfgang R Sperr, Christian Sillaber, Peter Valent

Leukemia research

2006

Case Reports, Journal Article, Research Support, Non-U.S. Gov't

Adrenal Cortex Hormones, Antineoplastic Agents, Antineoplastic Combined Chemotherapy Protocols, Benzamides, Cardiomyopathies, Eosinophil Cationic Protein, Humans, Hydroxyurea, Hypereosinophilic Syndrome, Imatinib Mesylate, Interferon-alpha, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Male, Mastocytosis, Systemic, Middle Aged, Oncogene Proteins, Fusion, Piperazines, Pyrimidines